Press release
published on April 15, 2024, at 6:00 p.m. CEST
Solvay publishes unaudited underlying Sales and EBITDA for the four quarters of 2023, before and after the restatements announced in the March 13th 2024 press release:
Summary table with Underlying EBITDA and Net Sales impacts:
in EUR million impact Underlying EBITDA Underlying net sales -------------------------------------------------------------------------------
2023 underlying figures, as
published 1,246 4,880
-------------------------------------------------------------------------------
phase-out thermal insulation
business scope -54 -107
-------------------------------------------------------------------------------
phase-out third party energy
supply activities scope -41 N/A
-------------------------------------------------------------------------------
Dis-synergies, net of the
"Transition Services Agreement"
mark-up scope -12 N/A
-------------------------------------------------------------------------------
Zhenjiang scope -8 -25
-------------------------------------------------------------------------------
Peroxidos do Brasil APM +23 +163
-------------------------------------------------------------------------------
2023 underlying figures, new
base 1,154 4,911
-------------------------------------------------------------------------------
This restated consolidated financial information provides for underlying Sales and EBITDA detailed information for the four quarters of 2023 for the new reporting segments:

  * Basic Chemicals host chemical intermediate businesses focused on mature and
    resilient markets. Solvay is a world leader in soda ash, bicarbonate, and
    peroxides. These global businesses share similar economic characteristics
    and serve major markets that include building and construction, consumer
    goods, and food.
  * Performance Chemicals host a wider range of products (in our Silica, Coatis
    and Special Chem businesses) that are subject to customization based on
    unique formulations and application expertise. These businesses share
    similar economic characteristics and are also high-quality assets with
    strong positions in their markets.
  * Corporate: comprises corporate and other business services, such as its
    Global Business services, as well as Procurement and Energy expertise.

It also reflects the transfer of the "eH2O2" (electronic-grade hydrogen

peroxide)  business from GBU  Special Chem to  GBU Peroxides (net  sales of EUR109
million,  underlying EBITDA of  EUR34 million in  2023), as if it  had happened on

January 1st, 2023.
About Solvay
Solvay, a pioneering chemical company with a legacy rooted in founder Ernest Solvay's pivotal innovations in the soda ash process, is dedicated to delivering
essential solutions globally through its workforce of over 9,000 employees. Since 1863, Solvay harnesses the power of chemistry to create innovative, sustainable solutions that answer the world's most essential needs such as purifying the air we breathe and the water we drink, preserving our food supplies, protecting our health and well-being, creating eco-friendly clothing, making the tires of our cars more sustainable and cleaning and protecting our homes. As a world-leading company with EUR4.9 billion in net sales in 2023 and
listings on Euronext Brussels and Paris (SOLB), its unwavering commitment drives
the transition to a carbon-neutral future by 2050, underscoring its dedication to sustainability and a fair and just transition. For more information about Solvay, please visit solvay.com (http://www.solvay.com) or follow Solvay (https://www.linkedin.com/company/solvay/) on Linkedin.
Safe harbor
This press release may contain forward-looking information. Forward-looking statements describe expectations, plans, strategies, goals, future events or intentions. The achievement of forward-looking statements contained in this press release is subject to risks and uncertainties relating to a number of factors, including general economic factors, interest rate and foreign currency exchange rate fluctuations, changing market conditions, product competition, the
nature of product development, impact of acquisitions and divestitures, restructurings, products withdrawals, regulatory approval processes, all-in scenario of R&I projects and other unusual items. Consequently, actual results or future events may differ materially from those expressed or implied by such forward-looking statements. Should known or unknown risks or uncertainties materialize, or should our assumptions prove inaccurate, actual results could vary materially from those anticipated. The Company undertakes no obligation to publicly update or revise any forward-looking statements.
Â